Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.pulmoe.2021.06.009 http://scihub22266oqcxt.onion/10.1016/j.pulmoe.2021.06.009 34315687!8257421!34315687     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pulmonology 2022 ; 28 (3): 164-172 Nephropedia Template TP {{tp|p=34315687|t=2022. Point-of-care COVID-19 antigen testing in German emergency rooms - a cost-benefit analysis |pdf=|usr=}}{{34315687}} gab.com Text Point-of-care COVID-19 antigen testing in German emergency rooms - a cost-benefit analysis JO: Pulmonology http://www.kidney.de/pget.php?&tw=1&pmid=34315687 #FOAvip BACKGROUND: The current COVID-19 pandemic is causing significant morbidity and death worldwide and produces significant socio-economic losses. OBJECTIVE: To assess the cost-benefit relation of implementing point-of-care COVID-19 antigen testing (POCT) in emergency rooms (ER) of German hospitals. METHODS: A deterministic decision-analytic model simulated the incremental costs of using the Sofia(R) SARS Antigen FIA test compared to those of using clinical judgement alone to confirm or exclude COVID-19 in adult patients in German ER, prior to hospitalization. Direct and indirect costs, with and without subsequent RT-PCR confirmation, were evaluated from the hospital perspective. RESULTS: With respect to ER patients, in base-case analysis, considering a COVID-19 prevalence of 15.6% and a hospitalization rate among COVID-19 suspects of 10.1%, POCT testing reduces average costs of hospitalized patients by euro213 per tested patient if nasopharyngeal swabs of patients suspected to have COVID-19 are also sent to external labs for RT-PCR testing. In probabilistic sensitivity analysis, under all reasonable assumptions, implementing the Sofia(R) SARS Antigen FIA saves on average about euro210 as compared to applying the clinical-judgement-only strategy. The major part of cost savings, euro159 or 75.9%, is due to the POC test s high specificity resulting in a 21-fold lower proportion of unnecessary bed blocking at the first day of hospitalization. CONCLUSIONS: Using highly specific rapid COVID-19 tests in COVID-19 suspects at German ER, despite of their sub-optimal sensitivity, may significantly reduce hospital expenditure. Twit Text FOAVip Point-of-care COVID-19 antigen testing in German emergency rooms - a cost-benefit analysis ????Pulmonology http://www.kidney.de/pget.php?&tw=1&pmid=34315687 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34315687 #FOAvip English Wikipedia <ref>{{Cite pmid|34315687}}</ref> Point-of-care COVID-19 antigen testing in German emergency rooms - a cost-benefit analysis #MMPMID34315687 Diel R; Nienhaus A Pulmonology 2022[May]; 28 (3): 164-172 PMID34315687show ga BACKGROUND: The current COVID-19 pandemic is causing significant morbidity and death worldwide and produces significant socio-economic losses. OBJECTIVE: To assess the cost-benefit relation of implementing point-of-care COVID-19 antigen testing (POCT) in emergency rooms (ER) of German hospitals. METHODS: A deterministic decision-analytic model simulated the incremental costs of using the Sofia(R) SARS Antigen FIA test compared to those of using clinical judgement alone to confirm or exclude COVID-19 in adult patients in German ER, prior to hospitalization. Direct and indirect costs, with and without subsequent RT-PCR confirmation, were evaluated from the hospital perspective. RESULTS: With respect to ER patients, in base-case analysis, considering a COVID-19 prevalence of 15.6% and a hospitalization rate among COVID-19 suspects of 10.1%, POCT testing reduces average costs of hospitalized patients by euro213 per tested patient if nasopharyngeal swabs of patients suspected to have COVID-19 are also sent to external labs for RT-PCR testing. In probabilistic sensitivity analysis, under all reasonable assumptions, implementing the Sofia(R) SARS Antigen FIA saves on average about euro210 as compared to applying the clinical-judgement-only strategy. The major part of cost savings, euro159 or 75.9%, is due to the POC test s high specificity resulting in a 21-fold lower proportion of unnecessary bed blocking at the first day of hospitalization. CONCLUSIONS: Using highly specific rapid COVID-19 tests in COVID-19 suspects at German ER, despite of their sub-optimal sensitivity, may significantly reduce hospital expenditure. |*COVID-19/diagnosis/epidemiology[MESH] |Adult[MESH] |Cost-Benefit Analysis[MESH] |Emergency Service, Hospital[MESH] |Humans[MESH] |Pandemics[MESH] |Point-of-Care Systems[MESH]Point-of-care COVID-19 antigen testing in German emergency rooms - a c(epmc).pdf DeepDyve Pubget Overpricing